Epinogen is a first-in-class anticancer drug discovery company based on advanced cryo-EM technology.
Epinogen Co., Ltd. has world-class advanced ultra-low temperature electron microscope structure identification technology, new drug target giant protein production and research technology, and ultra-fast structure-based ligand optimization technology.More
Epinogen Co., Ltd. has four leading pipelines and five follow-up pipelines, and aims to build and license out continuously.More
The excellence of targets by pipeline owned by Epinogen Co., Ltd. and major research contents.More
Headquarter: 2F 203-B63, 15, Gyeryong-ro 105beon-gil, Yuseong-gu, Daejeon, Republic of Korea
Research institute: 604, KBIZ DMC Tower, 189, Seongam-ro, Mapo-gu, Seoul, Korea 03929